Latest Breaking News On - Nina goworek - Page 1 : comparemela.com

Bristol Myers Squibb to Highlight Long-Term Growth Strategy at J.P. Morgan's 40th Annual Healthcare Conference

Press release content from Business Wire. The AP news staff was not involved in its creation.

United statesNina goworekBristol myers squibbGiovanni caforioAnnouncement of accelerated share repurchase programExchange commissionEuropean unionMyers squibbBristol myersAccelerated share repurchaseContinuing businessAccepted accounting principlesPrivate securities litigation reform actRecovery processAnnual reportQuarterly reports

Century Therapeutics and Bristol Myers Squibb Enter into a Strategic Collaboration to Develop iPSC-d

Collaboration brings together Century’s industry leading iPSC-derived allogeneic cell therapy platform with Bristol Myers Squibb’s expertise in cell therapy and oncology drug developmentFirst two programs include a program in acute myeloid leukemia and a program in multiple myeloma, which could incorporate either th.

United statesLalo floresNina goworekJoshuar mansbachRupert vesseyElizabeth krutoholowBristol myers squibbMelissa forst maghan meyersResearch early developmentExchange commissionCentury therapeuticsMyers squibbChief executive officerExecutive vice presidentEarly developmentBristol myers

Bristol Myers Squibb to Highlight Long-Term Growth Strategy at J.P. Morgan's 40th Annual Healthcare Conference

Spotlights Key Drivers of Growth for Upcoming Decade, Including Progress on New Launches and Forthcoming Clinical and Regulatory Milestones across Product PipelineAnnounces $5 Billion Accelerated Share Repurchase Agreement to Be Executed During the First QuarterProvides 2022 Total Revenue and Non-GAAP EPS GuidanceRe.

United statesNina goworekBristol myers squibbGiovanni caforioAnnouncement of accelerated share repurchase programExchange commissionEuropean unionSpotlights key driversUpcoming decadeIncluding progressNew launchesForthcoming clinicalRegulatory milestonesAccelerated share repurchase agreementBristol myersMyers squibb

Immatics and Bristol Myers Squibb Enter Into Global Exclusive License for Immatics' TCR Bispecific Program IMA401

Press release content from Business Wire. The AP news staff was not involved in its creation.

United statesMyers squibbNina goworekImmatic bispecificAnja heuerTeri foyBristol myers squibbCarsten reinhardtCelgene corporationBristol myers squibb companyExchange commissionEarly developmentClinical trial applicationTrial applicationInvestigational new drugChief development officer

Bristol Myers Squibb to Highlight More than 80 Abstracts at ASH 2021 Demonstrating Strength of Innovative Therapeutic Platforms Improving Outcomes for a Broad Range of Hematologic Diseases

Bristol Myers Squibb to Highlight More than 80 Abstracts at ASH 2021 Demonstrating Strength of Innovative Therapeutic Platforms Improving Outcomes for a Broad Range of Hematologic Diseases
investingnews.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from investingnews.com Daily Mail and Mail on Sunday newspapers.

United statesIdecabtagene vicleucel karmmaYumi nakayamaMaciej garbowskiChristopher parkerLeslie keanUwe platzbeckerHenry chanPaula rodriguez oteroVikas guptaNina shahAntonis kattamisJohn godwinIdecabtagene vicleucelJeremy abramsonBristol myers squibb